Skip to Content

Video

Pfizer shares gained 2.5%

Pfizer’s FDA approval is boosting these stocks

By Julia Horowitz, CNN Business Since 2020, investors have been rallying behind shares of Pfizer and Germany’s BioNTech, two companies that were poised to play a crucial role in helping bring an end to a devastating pandemic. Those bets have paid off. What’s happening: On Monday, the US Food and Drug Administration granted full approval

Continue Reading
The US could enter spring of 2022 with Covid-19 under control if enough people get vaccinated

Vaccines are less protective against Delta infection but still reduce risk by two-thirds, CDC study shows

By Michael Nedelman, Eric Levenson and Madeline Holcombe, CNN Vaccine effectiveness against Covid-19 infection dropped from 91% to 66% once the Delta variant accounted for the majority of circulating virus, according to a study published Tuesday by the US Centers for Disease Control and Prevention. “While we did see a reduction in the protection of

Continue Reading